These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15912812)

  • 1. [Meningococcus, serogroup C].
    Noack R
    Krankenpfl J; 2005; 43(1-3):16. PubMed ID: 15912812
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meningococcal infections. Every case a preventable tragedy].
    Bischoff A
    MMW Fortschr Med; 2008 Jun; 150(24):17. PubMed ID: 18605054
    [No Abstract]   [Full Text] [Related]  

  • 3. [Meningococcal infections].
    Rothfuss P
    Kinderkrankenschwester; 2010 Jan; 29(1):13-5. PubMed ID: 20151571
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidemiology of meningococcal infections in children in Loire-Atlantique and neighbouring areas from 1997 to 2002].
    Courtin V; Liet JM; Prat M; Picherot G; Rozé JC
    Arch Pediatr; 2005 Mar; 12(3):330. PubMed ID: 15734132
    [No Abstract]   [Full Text] [Related]  

  • 5. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 7. Invasive meningococcal disease associated with a very high case fatality rate in the North-West of Poland.
    Skoczyńska A; Kadłubowski M; Knap J; Szulc M; Janusz-Jurczyk M; Hryniewicz W
    FEMS Immunol Med Microbiol; 2006 Mar; 46(2):230-5. PubMed ID: 16487304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not meningitis but septic shock as the killer in acute meningococcal disease].
    Vos GD; Wiegman A; Romijn JA; Meurs AM; Bruins-Stassen MJ; Bijlmer RP; van Lieshout JJ
    Ned Tijdschr Geneeskd; 1989 Apr; 133(15):772-5. PubMed ID: 2716911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology and prevention of meningococcal illnesses--Europe, Germany].
    Dittmann S
    Krankenpfl J; 2004; 42(1-2):8-9. PubMed ID: 15116765
    [No Abstract]   [Full Text] [Related]  

  • 10. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease--Canada, 1991.
    Can Dis Wkly Rep; 1991 Dec; 17(52):293. PubMed ID: 1843664
    [No Abstract]   [Full Text] [Related]  

  • 12. ["Typical" symptoms are frequently absent. Every 10th meningococcal C infection is fatal].
    Fessler B
    MMW Fortschr Med; 2006 Dec; 148(51-52):19. PubMed ID: 17619339
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for control of meningococcal disease. The Advisory Committee on Epidemiology.
    Can Dis Wkly Rep; 1991 Nov; 17(45):245-50. PubMed ID: 1843653
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
    Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
    Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugate vaccine-induced immunological priming is not protective against acute meningococcal C infection.
    Spoulou VI; Moschou CK; Tzanakaki G; Theodoridou MC
    Vaccine; 2007 Oct; 25(41):7012-3. PubMed ID: 17707961
    [No Abstract]   [Full Text] [Related]  

  • 18. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.
    Kinlin LM; Jamieson F; Brown EM; Brown S; Rawte P; Dolman S; Drews SJ; Fisman DN
    Vaccine; 2009 Mar; 27(11):1735-40. PubMed ID: 19186206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-Fatality Rates and Sequelae Resulting from Neisseria meningitidis Serogroup C Epidemic, Niger, 2015.
    Coldiron ME; Salou H; Sidikou F; Goumbi K; Djibo A; Lechevalier P; Compaoré I; Grais RF
    Emerg Infect Dis; 2016 Oct; 22(10):1827-9. PubMed ID: 27649257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.